Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xeronacre+
- Development stage
- Preclinical
- Lead developer
- MEGA BIOPHARMA
- Modality
- Nanoparticles → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems, Device-based Delivery → Drug Delivery Systems
- Administration
- Topical
01
Overview
Xeronacre+ is a topical dermocosmetic and therapeutic product developed by MEGA BIOPHARMA for the treatment and alleviation of psoriasis symptoms. The product is based on the company's proprietary NACR-45® technology, which utilizes the biomaterial nacre (mother-of-pearl). Nacre is known for its biocompatibility and potential to support tissue regeneration and skin health. Xeronacre+ is intended to manage psoriasis-related skin issues through the natural properties of nacre rather than through traditional pharmacological pathways or molecular targets. It is categorized as a medical device or dermocosmetic product rather than a traditional pharmaceutical drug.
- Brand names
- Xeronacre+
- Other names
- Xeronacre
Beyond the preview
Go deeper on Xeronacre+.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xeronacre+.